Lista de obras - Fabian Pitoia - Dominio Público Uruguay

2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and Their Implementation in Various Care Settings

artículo científico publicado en 2015

A study of 34 cases of adrenal incidentaloma

artículo científico publicado en 2007

Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America

scientific article published on 02 September 2019

Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?

artículo científico publicado en 2021

Biochemical persistence in thyroid cancer: is there anything to worry about?

artículo científico publicado en 2013

Definition and management of radioactive iodine-refractory differentiated thyroid cancer

artículo científico publicado en 2014

Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy?

artículo científico publicado en 2001

Differences between Latin American and American Associations' thyroid cancer guidelines

artículo científico publicado en 2010

Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma.

artículo científico publicado en 2016

Dynamic risk assessment in patients with differentiated thyroid cancer

artículo científico publicado en 2019

Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer

artículo científico publicado en 2019

Effect of hypercortisolism control on high blood pressure in Cushing's syndrome

artículo científico publicado en 2007

Effects of sample storage and diluents in the reliability of thyroglobulin measurement in the washout of fine needle aspirates

artículo científico publicado en 2017

Epidemiology of palpable goiter in greater Buenos Aires, an iodine-sufficient area [corrected]

artículo científico publicado en 2004

Fatal outcome of a young woman with papillary thyroid carcinoma and graves' disease: possible implication of "cross-signalling" mechanism

artículo científico publicado en 2008

Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.

artículo científico publicado en 2006

High prevalence of thyroid disorders in relatives of patients with familial papillary thyroid cancer.

artículo científico publicado en 2010

High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance

scientific article published on 24 April 2020

Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer.

artículo científico publicado en 2018

Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer

artículo científico publicado en 2014

Introducing the thyroid gland as another victim of the insulin resistance syndrome.

artículo científico publicado en 2008

Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome

artículo científico publicado en 2007

Lack of increase in the serum thyroid-stimulating hormone level after intramuscular administration of recombinant human thyroid-stimulating hormone doses in a morbidly obese patient

artículo científico publicado en 2011

Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer

artículo científico

Metformin treatment for small benign thyroid nodules in patients with insulin resistance

artículo científico publicado en 2010

One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer

scientific article published on 01 May 2011

Optimum recombinant human thyrotropin dose in patients with differentiated thyroid carcinoma and end-stage renal disease.

artículo científico publicado en 2008

Outcomes of patients with bone metastases from differentiated thyroid cancer.

artículo científico publicado en 2018

Patients with familial non-medullary thyroid cancer have an outcome similar to that of patients with sporadic papillary thyroid tumors

artículo científico publicado en 2011

Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris

scientific article published on 01 January 2005

Primary thyroid disorders in endogenous Cushing's syndrome

artículo científico publicado en 2002

Protocol for thyroid remnant ablation after recombinant TSH in thyroid carcinoma.

artículo científico publicado en 2009

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation.

artículo científico publicado en 2017

Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions

artículo científico publicado en 2012

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer ⬇️

artículo científico publicado el 6 de diciembre de 2012

Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome.

artículo científico publicado en 2015

Rare complications of multikinase inhibitor treatment

artículo científico publicado en 2018

Real-life use of lenvatinib in patients with differentiated thyroid cancer: experience from Argentina

scientific article published on 06 April 2020

Recombinant human TSH versus thyroid hormone withdrawal.

artículo científico publicado en 2012

Recombinant human TSH: the Argentinean experience

artículo científico publicado en 2009

Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.

artículo científico publicado en 2009

Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma

artículo científico

Resolution of Cushing's syndrome and exacerbation of autoimmune thyroiditis

scientific article published on 01 February 2011

Response to sorafenib treatment in advanced metastatic thyroid cancer

artículo científico publicado en 2014

Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer.

artículo científico publicado en 2017

Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response?

artículo científico publicado en 2014

The "broken chair" in patients with differentiated thyroid cancer

artículo científico publicado en 2017

The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancer

scientific article published on 28 February 2019

Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH.

artículo científico publicado en 2016

Thyroid cancer in the Era of COVID-19

artículo científico publicado en 2020

Thyroid cancer: does the size matter?

artículo científico publicado en 2008

Thyroid dysfunction in adults infected by human immunodeficiency virus

artículo científico publicado en 2014

Timing of multikinase inhibitor initiation in differentiated thyroid cancer

artículo científico publicado en 2017

Tumour growth after recombinant human TSH.

artículo científico publicado en 2002

Undetectable pre-ablation thyroglobulin levels in patients with differentiated thyroid cancer: it is not always what it seems

artículo científico publicado en 2013

Unusual metastases from differentiated thyroid carcinoma: analysis of 36 cases

scientific article published on 20 July 2019

Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma

artículo científico publicado en 2006

Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH?

artículo científico publicado en 2004

[Recombinant human TSH in pediatric thyroid cancer]

artículo científico publicado en 2011

[Thyroid cancer. In search of individualized treatment]

artículo científico publicado en 2012

Lista de obras de Fabian Pitoia

2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and Their Implementation in Various Care Settings

A study of 34 cases of adrenal incidentaloma

Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America

Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?

Biochemical persistence in thyroid cancer: is there anything to worry about?

Definition and management of radioactive iodine-refractory differentiated thyroid cancer

Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy?

Differences between Latin American and American Associations' thyroid cancer guidelines

Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma.

Dynamic risk assessment in patients with differentiated thyroid cancer

Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer

Effect of hypercortisolism control on high blood pressure in Cushing's syndrome

Effects of sample storage and diluents in the reliability of thyroglobulin measurement in the washout of fine needle aspirates

Epidemiology of palpable goiter in greater Buenos Aires, an iodine-sufficient area [corrected]

Fatal outcome of a young woman with papillary thyroid carcinoma and graves' disease: possible implication of "cross-signalling" mechanism

Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.

High prevalence of thyroid disorders in relatives of patients with familial papillary thyroid cancer.

High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance

Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer.

Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer

Introducing the thyroid gland as another victim of the insulin resistance syndrome.

Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome

Lack of increase in the serum thyroid-stimulating hormone level after intramuscular administration of recombinant human thyroid-stimulating hormone doses in a morbidly obese patient

Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer

Metformin treatment for small benign thyroid nodules in patients with insulin resistance

One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer

Optimum recombinant human thyrotropin dose in patients with differentiated thyroid carcinoma and end-stage renal disease.

Outcomes of patients with bone metastases from differentiated thyroid cancer.

Patients with familial non-medullary thyroid cancer have an outcome similar to that of patients with sporadic papillary thyroid tumors

Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris

Primary thyroid disorders in endogenous Cushing's syndrome

Protocol for thyroid remnant ablation after recombinant TSH in thyroid carcinoma.

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation.

Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer ⬇️

Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome.

Rare complications of multikinase inhibitor treatment

Real-life use of lenvatinib in patients with differentiated thyroid cancer: experience from Argentina

Recombinant human TSH versus thyroid hormone withdrawal.

Recombinant human TSH: the Argentinean experience

Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.

Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma

Resolution of Cushing's syndrome and exacerbation of autoimmune thyroiditis

Response to sorafenib treatment in advanced metastatic thyroid cancer

Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer.

Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response?

The "broken chair" in patients with differentiated thyroid cancer

The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancer

Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH.

Thyroid cancer in the Era of COVID-19

Thyroid cancer: does the size matter?

Thyroid dysfunction in adults infected by human immunodeficiency virus

Timing of multikinase inhibitor initiation in differentiated thyroid cancer

Tumour growth after recombinant human TSH.

Undetectable pre-ablation thyroglobulin levels in patients with differentiated thyroid cancer: it is not always what it seems

Unusual metastases from differentiated thyroid carcinoma: analysis of 36 cases

Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma

Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH?

[Recombinant human TSH in pediatric thyroid cancer]

[Thyroid cancer. In search of individualized treatment]